Beijing Chunlizhengda Medical Instruments (01858) released its annual performance, with a net profit attributable to shareholders of 273 million yuan, an increase of 118.05% year-on-year.

Beijing Chunlizhengda Medical Instruments (01858) announced its annual performance for the year ending December 31, 2025. The group achieved operating income of 1.046 billion yuan, a year-on-year increase of 29.77%; net profit attributable to the parent company's shareholders was 273 million yuan, an increase of 118.05% year-on-year; basic earnings per share were 0.71 yuan. The announcement stated that the increase in net profit attributable to the parent company was mainly due to the continuous release of growth potential after the landing of the company's product group procurement, steady progress in international business, and steady growth in revenue driven by internal and external synergies. At the same time, the company continued to optimize its business management and resource allocation, further improving operational efficiency and profitability, collectively driving good performance growth.